These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

65 related items for PubMed ID: 8512460

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Human-derived vascular smooth muscle cells produce angiotensin II by changing to the synthetic phenotype.
    Hu WY, Fukuda N, Ikeda Y, Suzuki R, Tahira Y, Takagi H, Matsumoto K, Kanmatsuse K, Mugishima H.
    J Cell Physiol; 2003 Aug; 196(2):284-92. PubMed ID: 12811821
    [Abstract] [Full Text] [Related]

  • 3. Cross-talk between aldosterone and angiotensin II in vascular smooth muscle cell senescence.
    Min LJ, Mogi M, Iwanami J, Li JM, Sakata A, Fujita T, Tsukuda K, Iwai M, Horiuchi M.
    Cardiovasc Res; 2007 Dec 01; 76(3):506-16. PubMed ID: 17706954
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Insulin-stimulated NADH/NAD+ redox state increases NAD(P)H oxidase activity in cultured rat vascular smooth muscle cells.
    Yang M, Kahn AM.
    Am J Hypertens; 2006 Jun 01; 19(6):587-92. PubMed ID: 16733230
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Angiotensin II modulates frizzled-2 receptor expression in rat vascular smooth muscle cells.
    Castoldi G, Redaelli S, van de Greef WM, di Gioia CR, Busca G, Sperti G, Stella A.
    Clin Sci (Lond); 2005 Jun 01; 108(6):523-30. PubMed ID: 15667337
    [Abstract] [Full Text] [Related]

  • 9. Insulin-stimulated NAD(P)H oxidase activity increases migration of cultured vascular smooth muscle cells.
    Yang M, Foster E, Kahn AM.
    Am J Hypertens; 2005 Oct 01; 18(10):1329-34. PubMed ID: 16202857
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Antiproliferative action of an angiotensin I-converting enzyme inhibitory peptide, Val-Tyr, via an L-type Ca2+ channel inhibition in cultured vascular smooth muscle cells.
    Toshiro M, Ueno T, Tanaka M, Oka H, Miyamotq T, Osajima K, Matsumoto K.
    Hypertens Res; 2005 Jun 01; 28(6):545-52. PubMed ID: 16231761
    [Abstract] [Full Text] [Related]

  • 13. Cultured myofibroblasts generate angiotensin peptides de novo.
    Katwa LC, Campbell SE, Tyagi SC, Lee SJ, Cicila GT, Weber KT.
    J Mol Cell Cardiol; 1997 May 01; 29(5):1375-86. PubMed ID: 9201623
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Enhanced angiotensin receptor type 1 mRNA degradation and induction of polyribosomal mRNA binding proteins by angiotensin II in vascular smooth muscle cells.
    Nickenig G, Murphy TJ.
    Mol Pharmacol; 1996 Oct 01; 50(4):743-51. PubMed ID: 8863818
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.